About us
Research
Lowcountry Infectious Diseases conducts clinical research and provides novel pharmaceutical therapies for many types of infectious diseases. The clinical research trials are conducted in our office or hospital setting to provide volunteers with access to treatment options that may not be available to the public.
Our Clinical Trials
Nontuberculous Mycobacterial (NTM) Lung Infection caused by Mycobacterium Avium Complex (MAC)
ENCORE - A randomized, double-blind, placebo-controlled, active comparator, multicenter study to evaluate the efficacy and safety of an Amikacin Liposome Inhalation Suspension (ALIS)-based regimen in adult subjects with newly diagnosed nontuberculous mycobacterial (NTM) lung infection caused by mycobacterium avium complex (MAC).
Pulmonary Nontuberculous Mycobacterial Infection
A randomized, double-blind, placebo-controlled phase 2/3 study of the efficacy and safety of treatment with MNKD-101 (Clofazimine Inhalation Suspension) in combination with guideline-based therapy in patients with pulmonary nontuberculous mycobacterial infection followed by an open-label extension.
Recurrent Clostridioides Difficile Infection
A randomized, double-blind, placebo-controlled phase 3 study of VE303 for prevention of recurrent clostridioides difficile infection.